Cancer Insurance Global Market Report 2024

Description

Cancer insurance is an additional form of health coverage designed to assist with expenses arising from the diagnosis and treatment of cancer that go beyond what regular health insurance typically covers. This can encompass medical treatments, non-medical costs, income loss during treatment, and other related expenditures.

There are several types of cancer insurance, such as lung cancer and liver cancer coverage. Lung cancer insurance targets individuals specifically concerned about the risks associated with lung cancer, offering financial assistance for medical treatments, care, and associated expenses related to lung cancer diagnosis and treatment. These insurance plans are classified into individual plans, supplement plans, and critical illness plans. Distribution channels include brokers, bancassurance, agents, direct sales, and others, while the end users encompass both adults and children.

The cancer insurance market research report is one of a series of new reports from the business research company that provides cancer insurance market statistics, including cancer insurance industry global market size, regional shares, competitors with an cancer insurance market share, detailed cancer insurance market segments, market trends and opportunities, and any further data you may need to thrive in the cancer insurance industry. This cancer insurance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer insurance market size has grown strongly in recent years. It will grow from $70.00 billion in 2023 to $75.67 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. Historical growth can be traced to rising cancer incidence rates, medical inflation, heightened awareness and education, and potential premium increases reflecting higher treatment costs, economic expansion, governmental policies, and support.

The cancer insurance market size is expected to see strong growth in the next few years. It will grow to $103.76 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. Projected growth is anticipated due to an aging population, advancements in products and services, economic shifts, healthcare policies and regulations, awareness initiatives, marketing efforts, and the impact of pandemics. Key trends in the forecast period include innovative product developments for broader coverage, customizable policies adapted to personal requirements, integration with health plans or as supplementary options, and technological advancements influencing coverage offerings.

The increasing number of cancer cases is expected to drive the growth of the cancer insurance market in the future. This rise is mainly attributed to factors such as aging populations, lifestyle changes such as tobacco use and unhealthy diets, and environmental elements such as pollution and exposure to carcinogens. Cancer insurance offers financial protection by covering medical expenses and other related costs that regular health insurance may not cover, thus helping individuals cope with the substantial financial burdens associated with cancer treatment. For example, according to the International Agency for Research on Cancer (IARC) and the American Cancer Society (ACS), global cancer cases reached nearly 20 million in 2022, with projections indicating a 77% increase to 35 million annually by 2050. Lung cancer was the most prevalent (12.4%), followed by breast (11.6%) and colorectal cancers (9.6%). Lung cancer also accounted for the most deaths, causing 1.8 million fatalities (18.7%), followed by colorectal (9.3%) and liver cancers (7.8%). Therefore, the rising number of cancer cases is expected to boost the growth of the cancer insurance market.

Key players in the cancer insurance market are focusing on developing innovative insurance products, such as specialized cancer insurance policies tailored for women, to offer personalized coverage for their specific healthcare needs. These policies address the unique medical and financial requirements of female policyholders dealing with a cancer diagnosis, providing them with specialized coverage and assistance. For instance, Elephant.in, an India-based insurance company, introduced a unique cancer insurance policy specifically designed for women in March 2024. This policy aims to provide strong financial security to women facing the significant challenges of cancer diagnosis and treatment, covering the five main types of cancers affecting women-breast, cervical, ovarian, oral, and colorectal. It offers lump sum payouts upon diagnosis of any covered cancer, providing financial support ranging from ₹5,00,000 ($0.5 million) to ₹30,00,000 ($0.3 million).

In March 2024, Osara Health, a U.S.-based healthcare solutions provider, collaborated with Allstate Benefit to offer comprehensive cancer support programs to its policyholders. This partnership represents a significant development in the U.S. health insurance market, aiming to improve the overall cancer care experience for individuals battling cancer. Allstate Benefits, a U.S.-based insurance company specializing in cancer insurance policies, is part of this initiative.

Major companies operating in the cancer insurance market are UnitedHealth Group Incorporated, Ping An Insurance (Group) Company of China Ltd, Cigna Group, Allianz SE, Legal & General Group plc, AXA SA, Aetna Inc, MetLife Inc, Dai-ichi Life Holdings Inc, Munich Re Group, China Pacific Life Insurance Co Ltd, American International Group Inc, Liberty Mutual Insurance Company, China Life Insurance Company Limited, Zurich Insurance Group Ltd, MAPFRE SA, Huaxia Life Insurance Co Ltd, Aegon NV, AFLAC Incorporated, Atlas Cancer Insurance Services Ltd, Unum Group, Prudential plc, Bajaj Finserv Limited, Mutual of Omaha Insurance Company, Sun Life Financial Inc, Saga Plc

North America was the largest region in the cancer insurance market in 2023. The regions covered in the cancer insurance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer insurance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer insurance market includes revenues earned by entities by providing services such as lump-sum payments, non-medical expense coverage, support services, and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Insurance Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer insurance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer insurance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer insurance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Lung Cancer; Liver Cancer
2) By Insurance Plan: Individual Plan; Supplement Plan; Critical Illness Plan
3) By Distribution Channel: Brokers; Bancassurance; Agents; Direct Sales; Others Distribution Channels
4) By End-user: Adult; Children
Companies Mentioned: UnitedHealth Group Incorporated; Ping An Insurance (Group) Company of China Ltd; Cigna Group; Allianz SE; Legal & General Group plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18809

1. Executive Summary

2. Cancer Insurance Market Characteristics

3. Cancer Insurance Market Trends And Strategies

4. Cancer Insurance Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Cancer Insurance Market Size and Growth

5.1. Global Cancer Insurance Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cancer Insurance Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cancer Insurance Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cancer Insurance Market Segmentation

6.1. Global Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Lung Cancer
Liver Cancer
6.2. Global Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Individual Plan
Supplement Plan
Critical Illness Plan
6.3. Global Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Brokers
Bancassurance
Agents
Direct Sales
Others Distribution Channel
6.4. Global Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adult
Children

7. Cancer Insurance Market Regional And Country Analysis

7.1. Global Cancer Insurance Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cancer Insurance Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cancer Insurance Market

8.1. Asia-Pacific Cancer Insurance Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cancer Insurance Market

9.1. China Cancer Insurance Market Overview
9.2. China Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cancer Insurance Market

10.1. India Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cancer Insurance Market

11.1. Japan Cancer Insurance Market Overview
11.2. Japan Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cancer Insurance Market

12.1. Australia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cancer Insurance Market

13.1. Indonesia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cancer Insurance Market

14.1. South Korea Cancer Insurance Market Overview
14.2. South Korea Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cancer Insurance Market

15.1. Western Europe Cancer Insurance Market Overview
15.2. Western Europe Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cancer Insurance Market

16.1. UK Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cancer Insurance Market

17.1. Germany Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cancer Insurance Market

18.1. France Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cancer Insurance Market

19.1. Italy Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cancer Insurance Market

20.1. Spain Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cancer Insurance Market

21.1. Eastern Europe Cancer Insurance Market Overview
21.2. Eastern Europe Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cancer Insurance Market

22.1. Russia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cancer Insurance Market

23.1. North America Cancer Insurance Market Overview
23.2. North America Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cancer Insurance Market

24.1. USA Cancer Insurance Market Overview
24.2. USA Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cancer Insurance Market

25.1. Canada Cancer Insurance Market Overview
25.2. Canada Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cancer Insurance Market

26.1. South America Cancer Insurance Market Overview
26.2. South America Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cancer Insurance Market

27.1. Brazil Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cancer Insurance Market

28.1. Middle East Cancer Insurance Market Overview
28.2. Middle East Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cancer Insurance Market

29.1. Africa Cancer Insurance Market Overview
29.2. Africa Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cancer Insurance Market Competitive Landscape And Company Profiles

30.1. Cancer Insurance Market Competitive Landscape
30.2. Cancer Insurance Market Company Profiles
- 30.2.1. UnitedHealth Group Incorporated
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Ping An Insurance (Group) Company of China Ltd
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Cigna Group
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Allianz SE
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Legal & General Group plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Cancer Insurance Market Other Major And Innovative Companies

31.1. AXA SA
31.2. Aetna Inc
31.3. MetLife Inc
31.4. Dai-ichi Life Holdings Inc
31.5. Munich Re Group
31.6. China Pacific Life Insurance Co Ltd
31.7. American International Group Inc
31.8. Liberty Mutual Insurance Company
31.9. China Life Insurance Company Limited
31.10. Zurich Insurance Group Ltd
31.11. MAPFRE SA
31.12. Huaxia Life Insurance Co Ltd
31.13. Aegon NV
31.14. AFLAC Incorporated
31.15. Atlas Cancer Insurance Services Ltd

32. Global Cancer Insurance Market Competitive Benchmarking

33. Global Cancer Insurance Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cancer Insurance Market

35. Cancer Insurance Market Future Outlook and Potential Analysis

35.1 Cancer Insurance Market In 2028 - Countries Offering Most New Opportunities
35.2 Cancer Insurance Market In 2028 - Segments Offering Most New Opportunities
35.3 Cancer Insurance Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer